脑脊液
磁共振成像
医学
脉络丛
大脑大小
病理
血管周围间隙
内嗅皮质
神经学
灰质
脑室
心室
纵向研究
神经影像学
中枢神经系统
大脑结构与功能
脑形态计量学
薄壁组织
神经科学
基于体素的形态计量学
核医学
心脏病学
蛛网膜下腔
放射科
内科学
作者
Yuxin Li,Yu Zhao,Aocai Yang,Yuxing Wang,Jiaxiang Xin,Yufan Chen,Xuewen Xing,Fei Liu,Z G Yao,W B Zhao,Lin Song,Tao Gong,Guangbin Wang
摘要
INTRODUCTION: Lecanemab provides clinical benefits in early Alzheimer's disease (AD), but its longitudinal effects on brain structure, particularly cerebrospinal fluid (CSF) compartments, remain unclear. This study examined treatment-associated structural changes using longitudinal MRI. METHODS: Thirty-one patients with mild cognitive impairment (MCI) or early AD underwent baseline and follow-up (1-7 months) 3D T1-weighted MRI during lecanemab treatment. Gray matter (GM), ventricular, choroid plexus (CP), and perivascular space (PVS) volumes were quantified. Longitudinal changes were analyzed with paired tests and linear mixed-effects models (LMMs). RESULTS: Significant GM volume reductions were observed in AD-vulnerable regions (hippocampus, entorhinal cortex, precuneus), with increased CSF volumes. PVS volume showed a modest, non-significant decline. CP enlargement was associated with ventricular expansion. DISCUSSION: Lecanemab treatment was associated with coordinated parenchymal and CSF-related structural changes. CP and PVS dynamics may represent potential MRI-based markers for monitoring early AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI